NCT06417450

Usefulness of NESA Microcurrents in the Treatment of Children With Autism Spectrum Disorders

Utility of NESA Microcurrents in the Treatment of Sleep Disturbances, Disruptive Behaviours of Children With Autism Spectrum Disorders and in the Quality of Life of the Family Unit.
University of Las Palmas de Gran Canaria·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Autism Spectrum Disorder
Drug/Device/Intervention
Non-invasive Neuromodulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Las Palmas de Gran Canaria
Location
Las Palmas de Gran Canaria, Spain
Timeline & enrollment
Phase
N/A
Start date
May 13, 2024
End date
Sep 13, 2024
Enrollment
40 participants
Primary outcome

Change in sleep quality with the Sleep Disturbance Scale for Children (SDSC),Measuring sleep habits with the Children's Sleep Habits Questionnaire scale,Change in parent´s sleep quality with the Pittsburgh Sleep Quality Index (PSQI)

Summary

The term or definition of Autism Spectrum Disorder (ASD) defines a pervasive
 neurodevelopmental disorder in which deficits in communication and social interaction,
 altered sensorimotor behaviours, repetitive, restricted and stereotyped interests and
 activities are observed.
 
 One of the disorders most frequently associated with ASD, and which most affects the quality
 of life of the child and his or her family, is sleep disorders; it is estimated that between
 50 and 80 percent of children with ASD present this alteration and generally continue to
 suffer from it in adolescence and adulthood; It has also been observed that there is a
 correlation between sleep problems and an increase in aggressive behaviour, social and
 emotional deficits and deficits in activities of daily living, which severely affects the
 child and his or her close family environment; they become emotionally destabilised in a
 notorious way, and this has a negative impact on their work and productive environment.
 
 The microcurrents generated by the non-invasive neuromodulation device introduce, by means of
 a non-invasive technique (surface electrodes), electrical energy to normalise the nervous
 stimulus. This makes it an excellent complementary treatment to the activity of
 rehabilitation treatment. Its effects are achieved by establishing several input nerve
 pathways corresponding to the body's dermis, through which the signals are intellectualised
 in time-space. These signals are the basis for achieving normalisation of the nerve impulse
 by means of microcurrents.

ICD-10 classifications
Childhood autismAtypical autismAsperger syndromeNeurotic disorder, unspecifiedMental and behavioural disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06417450
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06417450 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Las Palmas de Gran Canaria and is currently Recruiting. The study focuses on Autism Spectrum Disorder. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.